Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frederic Brosseron

Showing results (41-50 of 108) with videos related to

Pageof 11
Sort By:
EMBO Molecular Medicine|March 5, 2016
sTREM2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early-stage Alzheimer's disease and associate with neuronal injury markersMarc Suárez-Calvet, Gernot Kleinberger, Miguel Ángel Araque Caballero, et al.
NPJ Digital Medicine|June 10, 2026
Smartphone-based detection of subtle memory decline in prodromal Alzheimer's diseaseSarah E Polk, Lindsay R Clark, Kristin Basche, et al.
Neurology|July 9, 2020
Minor neuropsychological deficits in patients with subjective cognitive declineSteffen Wolfsgruber, Luca Kleineidam, Jannis Guski, et al.
Frontiers in Aging Neuroscience|May 10, 2021
Hippocampal and Hippocampal-Subfield Volumes From Early-Onset Major Depression and Bipolar Disorder to Cognitive DeclineNiels Hansen, Aditya Singh, Claudia Bartels, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
BiomarkersMarianna Rizzo, Charlotte E Teunissen, Frederic Brosseron, et al.
Journal of Alzheimer'S Disease : JAD|October 10, 2019
Multicenter Tract-Based Analysis of Microstructural Lesions within the Alzheimer's Disease Spectrum: Association with Amyloid Pathology and Diagnostic UsefulnessStefan J Teipel, Jan O Kuper-Smith, Claudia Bartels, et al.
Alzheimer'S Research & Therapy|August 2, 2019
Which features of subjective cognitive decline are related to amyloid pathology? Findings from the DELCODE studyLisa Miebach, Steffen Wolfsgruber, Alexandra Polcher, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 27, 2025
Linking higher amyloid beta 1-38 (Aβ(1-38)) levels to reduced Alzheimer's disease progression riskLuisa Sophie Schneider, Silka Dawn Freiesleben, Gerard van Breukelen, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|September 14, 2019
Memorability of photographs in subjective cognitive decline and mild cognitive impairment: Implications for cognitive assessmentWilma A Bainbridge, David Berron, Hartmut Schütze, et al.
Journal of Alzheimer'S Disease : JAD|June 7, 2024
Symptomatic Clusters Related to Amyloid Positivity in Cognitively Unimpaired IndividualsLena Sannemann, Claudia Bartels, Frederic Brosseron, et al.
Pageof 11

Showing results (41-50 of 108) with videos related to

Sort By:
Pageof 11
EMBO Molecular Medicine|March 5, 2016
sTREM2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early-stage Alzheimer's disease and associate with neuronal injury markersMarc Suárez-Calvet, Gernot Kleinberger, Miguel Ángel Araque Caballero, et al.
NPJ Digital Medicine|June 10, 2026
Smartphone-based detection of subtle memory decline in prodromal Alzheimer's diseaseSarah E Polk, Lindsay R Clark, Kristin Basche, et al.
Neurology|July 9, 2020
Minor neuropsychological deficits in patients with subjective cognitive declineSteffen Wolfsgruber, Luca Kleineidam, Jannis Guski, et al.
Frontiers in Aging Neuroscience|May 10, 2021
Hippocampal and Hippocampal-Subfield Volumes From Early-Onset Major Depression and Bipolar Disorder to Cognitive DeclineNiels Hansen, Aditya Singh, Claudia Bartels, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
BiomarkersMarianna Rizzo, Charlotte E Teunissen, Frederic Brosseron, et al.
Journal of Alzheimer'S Disease : JAD|October 10, 2019
Multicenter Tract-Based Analysis of Microstructural Lesions within the Alzheimer's Disease Spectrum: Association with Amyloid Pathology and Diagnostic UsefulnessStefan J Teipel, Jan O Kuper-Smith, Claudia Bartels, et al.
Alzheimer'S Research & Therapy|August 2, 2019
Which features of subjective cognitive decline are related to amyloid pathology? Findings from the DELCODE studyLisa Miebach, Steffen Wolfsgruber, Alexandra Polcher, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 27, 2025
Linking higher amyloid beta 1-38 (Aβ(1-38)) levels to reduced Alzheimer's disease progression riskLuisa Sophie Schneider, Silka Dawn Freiesleben, Gerard van Breukelen, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|September 14, 2019
Memorability of photographs in subjective cognitive decline and mild cognitive impairment: Implications for cognitive assessmentWilma A Bainbridge, David Berron, Hartmut Schütze, et al.
Journal of Alzheimer'S Disease : JAD|June 7, 2024
Symptomatic Clusters Related to Amyloid Positivity in Cognitively Unimpaired IndividualsLena Sannemann, Claudia Bartels, Frederic Brosseron, et al.
Pageof 11